Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy.
about
Combining radiotherapy with sunitinib: lessons (to be) learnedImaging tumor hypoxia to advance radiation oncologyTheory, instrumentation, and applications of electron paramagnetic resonance oximetry.Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetryHypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3.Increased tumor oxygenation and drug uptake during anti-angiogenic weekly low dose cyclophosphamide enhances the anti-tumor effect of weekly tirapazamine.A method for measuring brain partial pressure of oxygen in unanesthetized unrestrained subjects: the effect of acute and chronic hypoxia on brain tissue PO(2).Temporal variation in the response of tumors to hyperoxia with breathing carbogen and oxygen.Radiotherapy in conjunction with 7-hydroxystaurosporine: a multimodal approach with tumor pO2 as a potential marker of therapeutic responseSynergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry.Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.A review of tasquinimod in the treatment of advanced prostate cancer.Measurement of pO2 by luminescence lifetime spectroscopy: A comparative study of the phototoxicity and sensitivity of [Ru(Phen)3 ]2+ and PdTCPP in vivo.Oxygen microenvironment affects the uptake of nanoparticles in head and neck tumor cells.Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas.Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomasAssessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response.Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonatorsTasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts.Tumor pO₂ as a surrogate marker to identify therapeutic window during metronomic chemotherapy of 9L gliomas.EPR Oximetry for Investigation of Hyperbaric O2 Pre-treatment for Tumor Radiosensitization.Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model.
P2860
Q26800587-8B29EBD9-66A9-4F3B-8E0E-C17121EF930DQ27007862-5BC60D8E-3FDF-4B79-8AE4-791AFA276B48Q33847052-319F5C30-3F38-4A66-B729-98165FBA84BDQ33882791-BF363530-152E-4512-8AE1-96CCEFE31524Q33945427-5E9E6EF1-76FC-41C0-B2A7-8CFA9849772EQ34028780-6CCECA38-14FB-4E02-AF97-57AAE09AAB8CQ34603497-F9804645-58FB-4FF8-B820-5FE854FEC887Q37415346-4AE1954A-64F2-4ADA-BB56-8323F45B5202Q37445556-6AF45DD9-63E5-45C8-882D-6F9CE9C5093FQ37639982-718BFC11-81C1-4914-A91A-9A659EC11384Q37718253-D56E3E2A-E267-467B-83F5-F67C593FA22EQ38105544-6277835F-FF8C-418E-9405-E56C80AC7F90Q39428442-82FCCBB3-6581-447B-A558-E30696748EFAQ39463261-87F3535A-0B49-4DBC-98D1-32D712F85CCEQ39556514-FF8CCB7D-3A4B-44E9-B519-2EC23C6D6BA2Q39660159-28245ED2-2337-445B-A5B4-1405058E190DQ40009198-4005E580-78EB-4006-B14E-1292C9DE2AFAQ41670802-75137677-568B-4ED2-A37F-137754421E16Q41760936-D45A9DBF-7008-444B-8AB3-0F953800D199Q41836745-2B255804-7E5A-4EC4-98A5-409DED1D4F78Q42838672-6EEEAA35-2ACA-4305-B35D-1288B052C4C9Q47398593-A0944977-0B4C-4C5E-84F2-C271EE91D0A7Q52764149-E44897D7-DA07-40D1-8911-BC5FF9B0609A
P2860
Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Repeated tumor pO
@nl
Repeated tumor pO(2) measureme ...... of fractionated radiotherapy.
@en
type
label
Repeated tumor pO
@nl
Repeated tumor pO(2) measureme ...... of fractionated radiotherapy.
@en
prefLabel
Repeated tumor pO
@nl
Repeated tumor pO(2) measureme ...... of fractionated radiotherapy.
@en
P2093
P2860
P1476
Repeated tumor pO(2) measureme ...... of fractionated radiotherapy.
@en
P2093
David Gladstone
Eugene Demidenko
Harold Swartz
Huagang Hou
Jean P Lariviere
Nadeem Khan
P2860
P304
P356
10.1016/J.RADONC.2008.10.015
P577
2008-11-14T00:00:00Z